SI BONE Inc (SIBN) News

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024

SANTA CLARA, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 8-K - Current report

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

Increases 2024 revenue guidance to $165 million - $167 millionExpects to achieve positive Adjusted EBITDA in...

Form 8-K - Current report

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company...

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]